| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 05/22/2008 | US20080119512 Carboxamide Derivatives as Therapeutic Agents |
| 05/22/2008 | US20080118584 Renal Synergistic Phyto-Nutraceutical Composition |
| 05/22/2008 | US20080118508 Complement pathway inhibitors binding to C5 and C5a without preventing formation of C5b |
| 05/22/2008 | CA2669669A1 Intra-vascular kidney gene therapy with plasmid encoding bmp-7 |
| 05/22/2008 | CA2669635A1 Piperidine derivative or salt thereof |
| 05/22/2008 | CA2665698A1 Use of spiro-oxindole compounds as therapeutic agents |
| 05/21/2008 | EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. |
| 05/21/2008 | EP1923388A1 Brain/neuronal cell-protecting agent, and therapeutic agent for sleep disorder |
| 05/21/2008 | EP1768948B1 Substituted amino compounds as 5-ht/na uptake inhibitors |
| 05/21/2008 | EP1448591B1 17alpha-alkyl-17beta-oxy-estratrienes and intermediates for the production thereof, and use of said 17alpha-alkyl-17beta-oxy-estratrienes for producing medicaments and pharmaceutical preparations |
| 05/21/2008 | EP1385508B1 Dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/21/2008 | EP1379492B1 Inhibitor of monoamine uptake |
| 05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
| 05/21/2008 | CN101184390A Reduced foam dispersions and formulations therefor |
| 05/21/2008 | CN101182449A Tortoise penis kidney-tonifying wine |
| 05/21/2008 | CN101181593A Chinese medicine prescription for curing prostate gland accretion |
| 05/21/2008 | CN101181582A Pharmaceutical composition for curing children's urorrhea and preparation method thereof |
| 05/21/2008 | CN101181575A Motherwort strip containing natural aromatic plant |
| 05/21/2008 | CN101181546A Medicine gruel for curing cystitis |
| 05/21/2008 | CN101181540A Application of pharmaceutical composition in the preparation of resistance prostatitis |
| 05/21/2008 | CN101181468A Chinese medicine composition orally taken for curing cystitis |
| 05/21/2008 | CN101181466A Chinese traditional medicine for curing nephrosis |
| 05/21/2008 | CN101181405A Chinese medicine for curing prostate gland sickness |
| 05/21/2008 | CN101181353A Traditional Chinese medicine preparation for curing prostate gland disease and preparation method thereof |
| 05/21/2008 | CN101181349A Application of Salvia przewalskii Maxim extract in the preparation of medicament for curing nephritis of renal glomerulus |
| 05/21/2008 | CN101181344A Chinese medicine medicament for curing renal calculs |
| 05/21/2008 | CN101181063A Nutrition health products for curing male infertility and sex hypofunction as well as preparing method thereof |
| 05/20/2008 | US7375215 Compounds for PDT |
| 05/20/2008 | US7375205 Elongase genes and uses thereof |
| 05/20/2008 | US7375199 Cancer-associated genes |
| 05/20/2008 | US7375131 NF-κB inhibitors |
| 05/20/2008 | US7375128 Inhibitors of α1 β2 integrin mediated cell adhesion |
| 05/20/2008 | US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
| 05/20/2008 | US7375113 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs |
| 05/20/2008 | US7375101 N-(7-chloro-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-N'-(5isoquinolinyl)-thiourea; bradykinin receptor B2 antagonists;analgesic; septic shock, pancreatitis, edema, rhinitis, asthma, colitis, arthritis, hepatorenal syndrome, cancer, bacterial and viral infections, ulcerative colitis |
| 05/20/2008 | US7374891 Receptor for Advanced Glycated Endproducts (RAGE); detecting binding of ligand and protein in presence of peptide, lipid, carbohydrate; amyloid, high-throughput colorimetric assay |
| 05/20/2008 | CA2432223C Pyrazole compounds useful as protein kinase inhibitors |
| 05/20/2008 | CA2430065C Salts of a isothiazole-4-carboxamide and their use as anti-hyperproliferation agents |
| 05/20/2008 | CA2415681C Pyrrolidine derivatives |
| 05/15/2008 | WO2008056687A1 Novel spiropiperidine derivative |
| 05/15/2008 | WO2008055840A1 Thiazole and oxazole-substituted arylamides |
| 05/15/2008 | US20080114171 Amorphous and crystalline forms of 1-azabicyclo[2.2.2]oct-3-yl-1-phenyl-3,4-dihydroisoquinoline-2-(1H)-carboxylate; stability, flowability, solubility |
| 05/15/2008 | US20080114014 Treating urinary and fecal incontinence in a patient being treated for a cognitive disorder consisting of one of a group of acute dementia and cognitive impairment by administration of a therapeutic amount of a quaternary ammonium anti-cholinergic muscarinic receptor antagonist |
| 05/15/2008 | US20080113996 Treatment of renal diseases or conditions associated with abnormal ion flux in a mammal such as a human which comprises the administration of a hPPAR gamma modulator or salt or solvate thereof, such as farglitazar or rosiglitazone |
| 05/15/2008 | US20080113989 For example, N-(1-Carbamoyl-1-oxo-3-phenylpropan-2-yl)-2-(E-2-(4-(1-pyrrolidinylmethyl)phenyl)ethen-1-yl)benzamide; calcium channel blockers; cardiovascular disorders; antiarthritic agents; inhibitors of enzymes, especially cysteine proteases such as calpain and cathepsins |
| 05/15/2008 | US20080113972 Enzyme inhibitors of cGMP-metabolizing phosphodiesterases, for TREATMENT OF CARDIOVASCULAR DIORDERS, CEREBROVASCULAR DISORDERS, UROGENITAL DISORDERS AND ERECTILE DYSFUNCTION; chemical synthesis |
| 05/15/2008 | US20080113959 {Beta}-Lactamyl vasopression V1a antagonists and methods of use |
| 05/15/2008 | US20080113934 Administering formulation containing pyrimido-pyrimidine selected from dipyridamole, mopidamol in combination with an agent selected fromacetylsalicylic acid (ASA), clopidogrel, ticlopidine; strongly influencing the interaction of the vessel wall with the fibrin pathway of the coagulation system |
| 05/15/2008 | US20080113428 Novel Polypeptide Hormone Phosphatonin |
| 05/15/2008 | US20080113024 Methods and compositions for treating platelet-related disorders |
| 05/15/2008 | US20080112918 Method for treating gout and binding uric acid |
| 05/15/2008 | CA2668399A1 Thiazole and oxazole-substituted arylamides |
| 05/14/2008 | EP1921133A2 System for processing lipoaspirate cells |
| 05/14/2008 | EP1921066A1 Pyridylphenol compound and use thereof |
| 05/14/2008 | EP1921065A1 Phenylpyridone derivative |
| 05/14/2008 | EP1919496A2 Abnormal glycosylation in tamm-horsfall protein in interstitial cystitis patient |
| 05/14/2008 | EP1601361B1 Pyridylsulfonamido pyrimidines for treating diabetic nephropathy |
| 05/14/2008 | EP1421084B1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/14/2008 | EP1390023B1 Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds |
| 05/14/2008 | EP1235934B1 Screening method for candidate drugs |
| 05/14/2008 | CN100387713C Polypeptides controlling phosphoric acid metabolism, calcium metabolism, calcification and vitamin D metabolism and DNAs encoding the same |
| 05/14/2008 | CN100387143C Method for preparing yang-invigorating, fatigue-alleviating soybean milk powder with micron pine pollen, antler powder, deer bone powder, deer sinew powder, bull penis powder and donkey penis powder |
| 05/13/2008 | US7371819 Differs from nucleotide sequence of wild-type IFN alpha -17 gene, in that it comprises one or several SNPs (Single Nucleotide Polymorphism[s]); anticarcinogenic and antiproliferative agents; side effect reduction |
| 05/13/2008 | US7371772 Bicyclic compound, production and use thereof |
| 05/13/2008 | US7371765 Quinoline derivatives having VEGF inhibiting activity |
| 05/13/2008 | US7371383 Genetic enginieered mixtures of complementary determining regions(CDR) antigens used for analyzing neutralizing epitopes and for prophylaxis of allergies and respiratory system disorders |
| 05/13/2008 | CA2437814C Human monoclonal antibodies to fc alpha receptor (cd89) |
| 05/13/2008 | CA2259012C S(-)-tolterodine in the treatment of urinary and gastrointestinal disorders |
| 05/13/2008 | CA2214894C Substituted dibenz[a,f]azulenes and methods of preparation |
| 05/08/2008 | WO2008053602A1 5-(1h-1,2,3-triazol-4-yl)-1h-pyrazole derivative |
| 05/08/2008 | WO2008053270A2 Use of an egfr antagonist for the treatment of glomerolonephritis |
| 05/08/2008 | WO2008052431A1 Use of composition comprising amlodipine in preparing medicaments for treating a lower urinary tract disorder |
| 05/08/2008 | US20080108808 Dipeptidyl peptidase inhibitors |
| 05/08/2008 | US20080108807 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile |
| 05/08/2008 | US20080108623 N-(4-(1-(2,6-difluorobenzyl)-5(((2-methoxyethyl)(methyl)amino)methyl)-2,4-dioxo-3-(2-pyridinyl)-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea; gonadotropin releasing hormone (GnRH) antagonist; sex hormone dependent disease, antitumor agent |
| 05/08/2008 | US20080108619 Dihydro-1,3,5-triazine amine derivatives and their therapeutic uses |
| 05/08/2008 | US20080108591 2-amino-3,6-dihydro-4-dimethyl-amino-6-ethyl-1,3,5-triazine hydrochloride; advanced glycosylation end-products inhibitor;antidiabetic, insulin resistance, neurodegenerative disorders, renal complications, atherosclerosis, angiopathy |
| 05/08/2008 | US20080108566 Analogues of GLP-1 |
| 05/08/2008 | DE102006049452A1 Substituierte Tetrahydropyrolopiperazin-Verbindungen und deren Verwendung in Arzneimitteln Tetrahydropyrolopiperazin substituted compounds and their use in medicaments |
| 05/07/2008 | EP1918279A2 1-(4-piperidinyl)-1,3-dihydro-2h-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and opioid receptor like receptor (ORL1) ligands for the treatment of pain |
| 05/07/2008 | EP1623740B1 Pharmaceutical composition and method for the treatment and prevention of prostatic hyperplasia and prostatitis using roystonea regia (royal palm) fruits |
| 05/07/2008 | EP1509216B1 Active ingredient salts and esters of 1-dimethylamino-3-(3-methoxy-phenyl)-2-methyl-pentan-3-ol and 3-(3-dimethylamino-1-ethyl-1-hydroxy-2-methyl-propyl)-phenol |
| 05/07/2008 | EP1436272B1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 05/07/2008 | EP1434792B1 Peptidyl ketones as inhibitors of dpiv |
| 05/07/2008 | EP1347981B1 Condensed purine derivatives as a 1 adenosine receptor antagonists |
| 05/07/2008 | EP1137666B1 Glp-1 analogues |
| 05/07/2008 | EP0991758B1 Smad6 and uses thereof |
| 05/07/2008 | CN101175751A Crystal of indole derivative having piperidine ring and process for production thereof |
| 05/07/2008 | CN101172158A Anti-CD26 monoclonal antibodies as therapy for diseases associated with cells expressing CD26 |
| 05/07/2008 | CN101172149A Traditional Chinese medicine prescription containing false wintergreen, barley roots for treating nephritis |
| 05/07/2008 | CN101172121A Uses of andrographis paniculata in preparing medicament for treating prostatitis |
| 05/07/2008 | CN101171927A Choline-silicic acid complex with osmolytes and divalent trace elements |
| 05/07/2008 | CN100386329C Substituted 3-amino-thieno(2,3-b)pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 05/07/2008 | CN100386326C 1-methylolimidazole [1,2-alpha] quinoxaline compound and its application |
| 05/07/2008 | CN100386076C Cardiovascular pharmaceutical formulation preparation method and uses |
| 05/06/2008 | US7368545 PCA3 messenger RNA species in benign and malignant prostate tissues |
| 05/06/2008 | US7368530 Human intestinal Npt2B |
| 05/06/2008 | US7368465 Metalloproteinase inhibitors |
| 05/06/2008 | US7368463 Substituted 4-amino-1-benzylpiperidine compounds |
| 05/06/2008 | US7368461 Compounds and method for the treatment of overactive bladder |